Acorda Therapeutics (ACOR) – Analyst EPS Change
-
Acorda Therapeutics, Inc. (ACOR) PT Lowered to $19 at Stifel
-
Acorda Therapeutics, Inc. (ACOR) PT Lowered to $16 at Cantor Fitzgerald; Tozadenant Serious Adverse Events Announcement a 'Clear Setback'
-
Back to ACOR Stock Lookup